MAPT and Alzheimer disease: We postulated that persulfidation of GSK3β would have protective effects against AD due to its role in inhibiting the enzyme and that loss of persulfidation caused by the decline of CSE levels due to age and disease would result in higher kinase activity and tau hyperphosphorylation (Fig. 11B).